Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes

Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes

Aims/Introduction:  In the present study, whether near‐future glycated hemoglobin (A1C) levels could be predicted by changes in glycated albumin (GA) levels before and after treatment for diabetes was investigated. Materials and Methods:  After starting diabetes treatment, GA and A1C levels are assu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes investigation 2011-08, Vol.2 (4), p.304-309
Hauptverfasser: Koga, Masafumi, Murai, Jun, Saito, Hiroshi, Kasayama, Soji
Format: Artikel
Sprache:eng
Schlagworte:
Glycated albumin
Glycated hemoglobin
Glycemic control
Original
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 309
container_issue 4
container_start_page 304
container_title Journal of diabetes investigation
container_volume 2
creator Koga, Masafumi
Murai, Jun
Saito, Hiroshi
Kasayama, Soji
description Aims/Introduction:  In the present study, whether near‐future glycated hemoglobin (A1C) levels could be predicted by changes in glycated albumin (GA) levels before and after treatment for diabetes was investigated. Materials and Methods:  After starting diabetes treatment, GA and A1C levels are assumed to change exponentially. From this assumption, the equation for predicting near‐future GA and A1C levels was derived. A total of 54 patients with type 2 diabetes mellitus in whom diabetes treatment was initiated or altered were enrolled. By incorporating GA and A1C values before and 2–4 weeks after starting treatment (second visit) into the equation, the predicted GA and A1C levels at the third visit (5–7 weeks after treatment) were obtained. Results:  A strong and positive correlation was observed between predicted GA and measured GA at the third visit (R = 0.669, P 
doi_str_mv 10.1111/j.2040-1124.2011.00107.x
format Article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4014972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1526731693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4907-c41800f7a0a563ad9e6f1f704e3d233dc5a6e0887712ec3fd6513224ace66953</originalsourceid><addsrcrecordid>eNpVkd9KHDEUxoO0VFFfoeSyN7vm3yQzIIVia6sIeuF9yMycrFkyE5tk7C544SP0GX0Ss1XXei6SA78v3znkQwhTMqeljpZzRgSZUcpE6SidE0KJmq920N4WfNj2VO6iw5SWpBSvaynVJ7TLRC14Rfgeur-K0LsuuzDiYPEIJj4-_LVTniLghV93JkOPb2AICx9aN2IPd-ATnpIbF28C49tpeKMt2FDem7EQmyHiHMHkAcaMC8C9My1kSAfoozU-weHLvY-uT39cn_yaXVz-PDv5djHrRENUOWlNiFWGmEpy0zcgLbWKCOA947zvKiOB1LVSlEHHbS8ryhkTpgMpm4rvo6_PtrdTO0DflTWi8fo2usHEtQ7G6fdkdDd6Ee60IFQ0ihWDLy8GMfyeIGU9uNSB92aEMCVNKyYVp7LhRfr5_1nbIa8_XgTHz4I_zsN6yynRm3D1Um9y05sM9SZc_S9cvdLn389Kw58AA-SbMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1526731693</pqid></control><display><type>article</type><title>Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes</title><source>Wiley Online Library Open Access</source><creator>Koga, Masafumi ; Murai, Jun ; Saito, Hiroshi ; Kasayama, Soji</creator><creatorcontrib>Koga, Masafumi ; Murai, Jun ; Saito, Hiroshi ; Kasayama, Soji</creatorcontrib><description>Aims/Introduction:  In the present study, whether near‐future glycated hemoglobin (A1C) levels could be predicted by changes in glycated albumin (GA) levels before and after treatment for diabetes was investigated. Materials and Methods:  After starting diabetes treatment, GA and A1C levels are assumed to change exponentially. From this assumption, the equation for predicting near‐future GA and A1C levels was derived. A total of 54 patients with type 2 diabetes mellitus in whom diabetes treatment was initiated or altered were enrolled. By incorporating GA and A1C values before and 2–4 weeks after starting treatment (second visit) into the equation, the predicted GA and A1C levels at the third visit (5–7 weeks after treatment) were obtained. Results:  A strong and positive correlation was observed between predicted GA and measured GA at the third visit (R = 0.669, P &lt; 0.0001). Similarly, a strong and positive correlation was observed between the predicted A1C and the measured A1C at the third visit (R = 0.795, P &lt; 0.0001). Conclusions:  GA and A1C levels 1–3 months after starting diabetes treatment could be predicted using the equation developed. The prediction of near‐future A1C levels using GA levels at two points would be useful for judging the effectiveness of ongoing diabetes treatment at an earlier stage. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00107.x, 2011)</description><identifier>ISSN: 2040-1116</identifier><identifier>EISSN: 2040-1124</identifier><identifier>DOI: 10.1111/j.2040-1124.2011.00107.x</identifier><identifier>PMID: 24843503</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Glycated albumin ; Glycated hemoglobin ; Glycemic control ; Original</subject><ispartof>Journal of diabetes investigation, 2011-08, Vol.2 (4), p.304-309</ispartof><rights>2011 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4907-c41800f7a0a563ad9e6f1f704e3d233dc5a6e0887712ec3fd6513224ace66953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014972/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014972/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,11542,27903,27904,45553,45554,46031,46455,53770,53772</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.2040-1124.2011.00107.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24843503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koga, Masafumi</creatorcontrib><creatorcontrib>Murai, Jun</creatorcontrib><creatorcontrib>Saito, Hiroshi</creatorcontrib><creatorcontrib>Kasayama, Soji</creatorcontrib><title>Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes</title><title>Journal of diabetes investigation</title><addtitle>J Diabetes Investig</addtitle><description>Aims/Introduction:  In the present study, whether near‐future glycated hemoglobin (A1C) levels could be predicted by changes in glycated albumin (GA) levels before and after treatment for diabetes was investigated. Materials and Methods:  After starting diabetes treatment, GA and A1C levels are assumed to change exponentially. From this assumption, the equation for predicting near‐future GA and A1C levels was derived. A total of 54 patients with type 2 diabetes mellitus in whom diabetes treatment was initiated or altered were enrolled. By incorporating GA and A1C values before and 2–4 weeks after starting treatment (second visit) into the equation, the predicted GA and A1C levels at the third visit (5–7 weeks after treatment) were obtained. Results:  A strong and positive correlation was observed between predicted GA and measured GA at the third visit (R = 0.669, P &lt; 0.0001). Similarly, a strong and positive correlation was observed between the predicted A1C and the measured A1C at the third visit (R = 0.795, P &lt; 0.0001). Conclusions:  GA and A1C levels 1–3 months after starting diabetes treatment could be predicted using the equation developed. The prediction of near‐future A1C levels using GA levels at two points would be useful for judging the effectiveness of ongoing diabetes treatment at an earlier stage. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00107.x, 2011)</description><subject>Glycated albumin</subject><subject>Glycated hemoglobin</subject><subject>Glycemic control</subject><subject>Original</subject><issn>2040-1116</issn><issn>2040-1124</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpVkd9KHDEUxoO0VFFfoeSyN7vm3yQzIIVia6sIeuF9yMycrFkyE5tk7C544SP0GX0Ss1XXei6SA78v3znkQwhTMqeljpZzRgSZUcpE6SidE0KJmq920N4WfNj2VO6iw5SWpBSvaynVJ7TLRC14Rfgeur-K0LsuuzDiYPEIJj4-_LVTniLghV93JkOPb2AICx9aN2IPd-ATnpIbF28C49tpeKMt2FDem7EQmyHiHMHkAcaMC8C9My1kSAfoozU-weHLvY-uT39cn_yaXVz-PDv5djHrRENUOWlNiFWGmEpy0zcgLbWKCOA947zvKiOB1LVSlEHHbS8ryhkTpgMpm4rvo6_PtrdTO0DflTWi8fo2usHEtQ7G6fdkdDd6Ee60IFQ0ihWDLy8GMfyeIGU9uNSB92aEMCVNKyYVp7LhRfr5_1nbIa8_XgTHz4I_zsN6yynRm3D1Um9y05sM9SZc_S9cvdLn389Kw58AA-SbMw</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Koga, Masafumi</creator><creator>Murai, Jun</creator><creator>Saito, Hiroshi</creator><creator>Kasayama, Soji</creator><general>Blackwell Publishing Ltd</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201108</creationdate><title>Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes</title><author>Koga, Masafumi ; Murai, Jun ; Saito, Hiroshi ; Kasayama, Soji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4907-c41800f7a0a563ad9e6f1f704e3d233dc5a6e0887712ec3fd6513224ace66953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Glycated albumin</topic><topic>Glycated hemoglobin</topic><topic>Glycemic control</topic><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koga, Masafumi</creatorcontrib><creatorcontrib>Murai, Jun</creatorcontrib><creatorcontrib>Saito, Hiroshi</creatorcontrib><creatorcontrib>Kasayama, Soji</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Koga, Masafumi</au><au>Murai, Jun</au><au>Saito, Hiroshi</au><au>Kasayama, Soji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes</atitle><jtitle>Journal of diabetes investigation</jtitle><addtitle>J Diabetes Investig</addtitle><date>2011-08</date><risdate>2011</risdate><volume>2</volume><issue>4</issue><spage>304</spage><epage>309</epage><pages>304-309</pages><issn>2040-1116</issn><eissn>2040-1124</eissn><abstract>Aims/Introduction:  In the present study, whether near‐future glycated hemoglobin (A1C) levels could be predicted by changes in glycated albumin (GA) levels before and after treatment for diabetes was investigated. Materials and Methods:  After starting diabetes treatment, GA and A1C levels are assumed to change exponentially. From this assumption, the equation for predicting near‐future GA and A1C levels was derived. A total of 54 patients with type 2 diabetes mellitus in whom diabetes treatment was initiated or altered were enrolled. By incorporating GA and A1C values before and 2–4 weeks after starting treatment (second visit) into the equation, the predicted GA and A1C levels at the third visit (5–7 weeks after treatment) were obtained. Results:  A strong and positive correlation was observed between predicted GA and measured GA at the third visit (R = 0.669, P &lt; 0.0001). Similarly, a strong and positive correlation was observed between the predicted A1C and the measured A1C at the third visit (R = 0.795, P &lt; 0.0001). Conclusions:  GA and A1C levels 1–3 months after starting diabetes treatment could be predicted using the equation developed. The prediction of near‐future A1C levels using GA levels at two points would be useful for judging the effectiveness of ongoing diabetes treatment at an earlier stage. (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2011.00107.x, 2011)</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>24843503</pmid><doi>10.1111/j.2040-1124.2011.00107.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 2040-1116
ispartof Journal of diabetes investigation, 2011-08, Vol.2 (4), p.304-309
issn 2040-1116
2040-1124
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4014972
source Wiley Online Library Open Access
subjects Glycated albumin
Glycated hemoglobin
Glycemic control
Original
title Prediction of near‐future glycated hemoglobin levels using glycated albumin levels before and after treatment for diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A54%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prediction%20of%20near%E2%80%90future%20glycated%20hemoglobin%20levels%20using%20glycated%20albumin%20levels%20before%20and%20after%20treatment%20for%20diabetes&rft.jtitle=Journal%20of%20diabetes%20investigation&rft.au=Koga,%20Masafumi&rft.date=2011-08&rft.volume=2&rft.issue=4&rft.spage=304&rft.epage=309&rft.pages=304-309&rft.issn=2040-1116&rft.eissn=2040-1124&rft_id=info:doi/10.1111/j.2040-1124.2011.00107.x&rft_dat=%3Cproquest_24P%3E1526731693%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1526731693&rft_id=info:pmid/24843503&rfr_iscdi=true